Filing Flows › Comparisons › RDGL vs GUTS
Vivos vs Fractyl Health: RDGL and GUTS compared
Vivos is the larger company: $36K of revenue in its latest quarter (Q2 2026) against $3K for Fractyl Health (Q4 2024). Vivos is growing faster (+143% against -57% a year earlier).
Where the money goes: RDGL and GUTS
Vivos (RDGL) · Q2 2026
Vivos, Q2 2026: revenue $36K (+143% year over year), net loss $830K, operating cash flow −$740K. The chart follows the revenue to costs, profit and cash.
Fractyl Health (GUTS) · Q4 2024
Fractyl Health, Q4 2024: revenue $3K (-57% year over year), net loss $25.0M, operating cash flow −$17.0M. The chart follows the revenue to costs, profit and cash.
| Vivos (RDGL) | Fractyl Health (GUTS) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q4 2024 |
| Revenue | $36K | $3K |
| Revenue growth, Y/Y | +143% | -57% |
| Operating margin | n/m | n/m |
| Net earnings | −$830K | −$25.0M |
| Operating cash flow | −$740K | −$17.0M |
Questions
Which is bigger, Vivos or Fractyl Health?
Vivos is the larger company: $36K of revenue in its latest quarter (Q2 2026) against $3K for Fractyl Health (Q4 2024).
Is Vivos or Fractyl Health growing faster?
Vivos is growing faster (+143% against -57% a year earlier).
More: Vivos earnings · how Vivos makes money · Fractyl Health earnings · how Fractyl Health makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-K filed Mar 3, 2025). Fiscal quarters can end on different dates. Not investment advice.